<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Rilzabrutinib for blood disorder shows promise in phase 1&#8211;2 clinical trial: Drug may safely boost platelet levels in patients with immune thrombocytopenia.	</title>
	<atom:link href="https://reporter-8fo.pages.dev/rilzabrutinib-for-blood-disorder-shows-promise-in-phase-1-2-clinical-trial-drug-may-safely-boost-platelet-levels-in-patients-with-immune-thrombocytopenia/feed/" rel="self" type="application/rss+xml" />
	<link>https://reporter-8fo.pages.dev/rilzabrutinib-for-blood-disorder-shows-promise-in-phase-1-2-clinical-trial-drug-may-safely-boost-platelet-levels-in-patients-with-immune-thrombocytopenia/</link>
	<description>News Around the world</description>
	<lastBuildDate>Wed, 20 Apr 2022 03:08:43 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.0.2</generator>
</channel>
</rss>
